LabCompass

Yoshinobu Koguchi

Medicine · The Ohio State University

Established · publishing since 1981

Publications

122

Citations

3,889

Est. group size

Recurring co-author estimate

Active years

46

Publishing since 1981

Research summary
AI-generated

Yoshinobu Koguchi studies how the immune system responds to cancer, focusing on cancer immunotherapy in tumors such as head and neck, lung, kidney, and breast cancer. Their work examines immune checkpoint therapies (like anti-PD-1, anti-LAG-3, and anti-GITR), cancer vaccines, and T cell behavior within tumors, using tools such as multi-omics profiling, mass spectrometry, and single-cell sequencing to identify biomarkers and immune targets that could improve treatment outcomes.

Cancer immunotherapy and checkpoint blockadeTumor microenvironment and T cell exhaustionCancer vaccines (including 'dark matter'/non-canonical antigen vaccines)Biomarker discovery via multi-omics and mass spectrometryClinical trials in solid tumors (lung, head and neck, breast, kidney cancers)

Publication output has grown over the past decade, rising from around 3-7 papers per year in 2017-2021 to a higher and more variable pace of 5-13 papers per year in 2022-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 8.6/year recently
2017: 7 publications172018: 4 publications182019: 3 publications192020: 5 publications202021: 5 publications212022: 13 publications13222023: 12 publications232024: 5 publications242025: 11 publications252026: 2 publications26
Recent publications
Publishes in
  • Regular and Young Investigator Award Abstracts×18
  • Journal for ImmunoTherapy of Cancer×9
  • The Journal of Immunology×9
  • Cancer Research×6
  • Journal of Clinical Oncology×5
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile